申请人:Adapt Pharma Limited
公开号:US20210093557A1
公开(公告)日:2021-04-01
Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising an opioid receptor antagonist, are provided. Methods of treating opioid overdose or its symptoms with the inventive drug products are also provided.